Nassim Usman Ph.D.
Net Worth

Last updated:

What is Nassim Usman Ph.D. net worth?

The estimated net worth of Dr. Nassim Usman Ph.D. is at least $7,691,800 as of 9 Aug 2022. He has received compensation worth at least $7,691,800 in Catalyst Biosciences, Inc..

What is the salary of Nassim Usman Ph.D.?

Dr. Nassim Usman Ph.D. salary is $769,180 per year as Pres, Chief Executive Officer & Director in Catalyst Biosciences, Inc..

How old is Nassim Usman Ph.D.?

Dr. Nassim Usman Ph.D. is 65 years old, born in 1960.

What stocks does Nassim Usman Ph.D. currently own?

As insider, Dr. Nassim Usman Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Catalyst Biosciences, Inc. (CBIO) Pres, Chief Executive Officer & Director 24,541 $0 $0

What does Catalyst Biosciences, Inc. do?

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD); and CB 4332 for patients with deficiencies in complement factor I (CFI), including dAMD. The company also develops ProTUNE C3b/C4b degrader and ImmunoTUNE C3a/C5a degrader platforms designed to target other disorders of the complement or inflammatory pathways. It has a strategic research collaboration with Mosaic Biosciences, Inc.; and license and collaboration agreement with Biogen International GmbH. Catalyst Biosciences, Inc. was founded in 2002 and is headquartered in South San Francisco, California.

CBIO logo
CBIO
Catalyst Biosciences, Inc.

Nassim Usman Ph.D. insider trading

Catalyst Biosciences, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 3,250 $0.47 $1,528
Purchase
Common Stock 3,250 $0.46 $1,495
Purchase
Common Stock 867 $3.62 $3,139
Option
Stock Option (Right to Buy) 5,000 $4.63 $23,150
Option
Common Stock 5,000 N/A N/A
Purchase
Common Stock 582 $4.81 $2,799
Purchase
Common Stock 582 N/A N/A
Purchase
Common Stock 4,000 N/A N/A
Option
Common Stock 4,400 N/A N/A
Option
Stock Option (Right to Buy) 4,400 $4.63 $20,372
Option
Stock Option (Right to Buy) 5,729 $4.63 $26,525
Option
Common Stock 5,729 $4.63 $26,525
Option
Common Stock 88 $4.63 $407
Option
Stock Option (Right to Buy) 88 $4.63 $407
Purchase
Common Stock 4,000 $2 $8,000

Catalyst Biosciences key executives

Catalyst Biosciences, Inc. executives and other stock owners filed with the SEC:

  • Dr. Howard Levy M.B.B.Ch., M.M.M., Ph.D. (71) Consultant
  • Dr. Nassim Usman Ph.D. (65) Pres, Chief Executive Officer & Director